Location History:
- Huntington Beach, CA (US) (2015)
- Fallston, MD (US) (1985 - 2023)
Company Filing History:
3 out of 3,688 
3 out of 24 
1 out of 1 Years Active: 1985-2023
Title: Innovations of David A Sack in Enterotoxigenic Diarrhea Treatment
Introduction
David A Sack is a notable inventor based in Fallston, MD (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines and treatments for enterotoxigenic diarrhea. With a total of 6 patents to his name, Sack's work has had a profound impact on public health.
Latest Patents
One of Sack's latest patents focuses on multiepitope fusion antigens and vaccines for the treatment of enterotoxigenic diarrhea. This patent describes polypeptides that comprise up to nine antigenic elements of ETEC virulence determinants. These include seven CFA adhesins expressed by the most prevalent and virulent ETEC strains, as well as two toxins expressed by all ETEC strains. The genetically fused proteins are designed for CFA-toxoid fusion, which aims to enhance the efficacy of vaccines against ETEC-related diseases.
Career Highlights
Throughout his career, David A Sack has worked with prestigious institutions such as Johns Hopkins University and South Dakota State University. His research has been pivotal in advancing the understanding and treatment of enterotoxigenic diarrhea, a condition that affects millions worldwide.
Collaborations
Sack has collaborated with esteemed colleagues, including Weiping Zhang and Charles B Stephensen. These partnerships have further enriched his research and contributed to the development of innovative solutions in the medical field.
Conclusion
David A Sack's contributions to the field of medical research, particularly in the area of enterotoxigenic diarrhea treatment, highlight his role as a leading inventor. His innovative patents and collaborations continue to pave the way for advancements in healthcare.